Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson(MRC University of Glasgow Centre for Virus Research), Massimo Galli(Luigi Sacco Hospital), Gyorgy Snell(VIR Biotechnology (United States)), Ivy Zhang(Memorial Sloan Kettering Cancer Center), Matteo Samuele Pizzuto(Vir Biotechnology (Switzerland)), Natasha Jesudason(MRC University of Glasgow Centre for Virus Research), Katja Culap(Vir Biotechnology (Switzerland)), Josh R. Dillen(VIR Biotechnology (United States)), Laura E. Rosen(VIR Biotechnology (United States)), Ruth F. Jarrett(MRC University of Glasgow Centre for Virus Research), Aoife M. Harbison(National University of Ireland, Maynooth), Christopher Davis(California University of Pennsylvania), Kyriaki Nomikou(MRC University of Glasgow Centre for Virus Research), Vattipally B. Sreenu(MRC University of Glasgow Centre for Virus Research), Jason A. Wojcechowskyj(KWJ Engineering (United States)), Tristan I. Croll(Institute of Occupational Medicine), Christian Garzoni(Clinica Luganese Moncucco), Spyros Lytras(The University of Tokyo), Anna De Marco(Vir Biotechnology (Switzerland)), Stefano Jaconi(Vir Biotechnology (Switzerland)), Federica Sallusto(Unknown), Martina Beltramello(Vir Biotechnology (Switzerland)), Nadine Czudnochowski(VIR Biotechnology (United States)), Jay C. Nix(Lawrence Berkeley National Laboratory), William G. Glass(Memorial Sloan Kettering Cancer Center), Jenna Nichols(MRC University of Glasgow Centre for Virus Research), David J. Pascall(University of Cambridge), L. Tong(MRC University of Glasgow Centre for Virus Research), James G. Shepherd(MRC University of Glasgow Centre for Virus Research), Paolo Ferrari(Hypertension Institute), Ana da Silva Filipe(MRC University of Glasgow Centre for Virus Research), Dora Pinto(Unidade Local de Saúde de São José), Áine O’Toole(University of Edinburgh), Marcel Meury(VIR Biotechnology (United States)), Katherine Smollett(MRC University of Glasgow Centre for Virus Research), Kathy Li(MRC University of Glasgow Centre for Virus Research), Rachel Colquhoun(University of Edinburgh), Luca Piccoli(Vir Biotechnology (Switzerland)), Stephen Carmichael(MRC University of Glasgow Centre for Virus Research), Roberto Spreafico(VIR Biotechnology (United States)), Elisabetta Cameroni(Vir Biotechnology (Switzerland)), Arthur Wickenhagen(National Institutes of Health), Alessandro Ceschi(Laboratory for Biomedical Neurosciences), Andrew Rambaut(University of Edinburgh), Julia di Iulio(VIR Biotechnology (United States)), Jessica Bassi(Vir Biotechnology (Switzerland)), Ben Jackson(University of Edinburgh), Rajiv Shah(MRC University of Glasgow Centre for Virus Research), Natasha Johnson(MRC University of Glasgow Centre for Virus Research), Daniel Mair(MRC University of Glasgow Centre for Virus Research), Fabrizia Zatta(Vir Biotechnology (Switzerland))
Cited by 656
Related Papers
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
|Nature Microbiology|2020|3k
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
|Nature|2021|1.3k
Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool
|Virus Evolution|2021|1.3k